Caladrius Biosciences Inc...

NASDAQ: CLBS · Real-Time Price · USD
0.43
-0.08 (-16.05%)
At close: Sep 15, 2022, 6:00 AM

Caladrius Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
33.35M 12.75M 94.97M 12.77M 12.94M 28.74M
Short-Term Investments
39.64M 75.77M 151K 87.38M 93.16M 82.77M
Long-Term Investments
10M n/a n/a n/a n/a n/a
Other Long-Term Assets
648K 708K 764K 361K 42K 41K
Receivables
n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
1.96M 2.18M -151K 1.96M 1.99M 2.52M
Total Current Assets
74.95M 90.7M 94.97M 102.11M 108.08M 114.03M
Property-Plant & Equipment
282K 55K 62K 70K 492K 533K
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
10.93M 763K 826K 431K 534K 574K
Total Assets
85.88M 91.46M 97.01M 102.54M 108.61M 114.61M
Account Payables
1.1M 697K 1.93M 768K 1.24M 2.31M
Deferred Revenue
n/a n/a n/a n/a n/a n/a
Short-Term Debt
178K 205K n/a 297K 366K 381K
Other Current Liabilities
2.08M 1.9M 2.59M 3.01M 2.25M 1.74M
Total Current Liabilities
3.36M 2.8M 4.52M 4.07M 3.86M 4.44M
Long-Term Debt
383K 421K n/a 53K 79K n/a
Other Long-Term Liabilities
n/a n/a 485K n/a n/a 155K
Total Long-Term Liabilities
383K 421K 485K 53K 79K 155K
Total Liabilities
3.74M 3.22M 5.01M 4.13M 3.94M 4.59M
Total Debt
561K 626K n/a 350K 445K 536K
Common Stock
61K 61K 60K 60K 60K 60K
Retained Earnings
-463.87M -457.24M -453.02M -446.22M -439.3M -433.61M
Comprehensive Income
-70K -196K -70K -64K -17K -72K
Shareholders Equity
82.39M 88.5M 92M 98.67M 104.93M 110.27M
Total Investments
49.64M 75.77M 151K 87.38M 93.16M 82.77M